CXCL16 and neoplasm: Moreover, CXCL16, a chemoattractant for CXCR6 expressing tumor cells, has been linked to an increase in tumor cell migration and invasion in prostate cancer [132] and pancreatic ductal adenocarcinoma (PDAC) [133].